EMA — authorised 5 September 2011
- Marketing authorisation holder: Janssen-Cilag International N.V.
- Status: approved
EMA authorised Zytiga on 5 September 2011
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 5 September 2011.
Janssen-Cilag International N.V. holds the EU marketing authorisation.